D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Cintas
CTAS
$80.9B
| $3.45M | ﹤0.01% |
30,564
+12,028
| +65% | +$1.3M |
|
2302
PUT
Consolidated Edison
ED
$39.6B
| $3.45M | ﹤0.01% |
36,200
-1,500
| -4% | -$136K |
|
2303
PUT
Ferrari
RACE
$70.4B
| $3.45M | ﹤0.01% |
16,100
-10,000
| -38% | -$2.06M |
|
2304
ProFrac Holding
ACDC
$745M
| $3.45M | ﹤0.01% |
+136,832
| New | +$3.02M |
|
2305
OneMain Financial
OMF
$7.54B
| $3.45M | ﹤0.01% |
103,492
+9,913
| +11% | +$351K |
|
|
SWI
2306
DELISTED
SolarWinds Corporation Common Stock
SWI
| $3.45M | ﹤0.01% |
368,176
-146,863
| -29% | -$1.28M |
|
|
ZLS
2307
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
| $3.45M | ﹤0.01% |
344,591
| – | – |
|
2308
Central Pacific Financial
CPF
$1.03B
| $3.45M | ﹤0.01% |
169,880
+8,557
| +5% | +$176K |
|
2309
Nabors Industries
NBR
$1.25B
| $3.44M | ﹤0.01% |
22,214
+19,583
| +744% | +$2.92M |
|
|
VRNA
2310
DELISTED
Verona Pharma
VRNA
| $3.44M | ﹤0.01% |
+131,468
| New | +$1.75M |
|
2311
The Greenbrier Companies
GBX
$1.54B
| $3.43M | ﹤0.01% |
+102,427
| New | +$3.41M |
|
2312
Xcel Energy
XEL
$48.1B
| $3.43M | ﹤0.01% |
48,901
-189,624
| -79% | -$12.6M |
|
2313
Ligand Pharmaceuticals
LGND
$5.92B
| $3.43M | ﹤0.01% |
+51,301
| New | +$3.34M |
|
2314
PUT
Waters Corp
WAT
$38B
| $3.43M | ﹤0.01% |
+10,000
| New | +$3.16M |
|
|
CLVT.PRA
2315
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $3.42M | ﹤0.01% |
90,000
| – | – |
|
2316
CALL
Keysight
KEYS
$57.5B
| $3.42M | ﹤0.01% |
20,000
| – | – |
|
2317
Bilibili
BILI
$7.88B
| $3.42M | ﹤0.01% |
+144,292
| New | +$2.3M |
|
|
CUK
2318
DELISTED
Carnival PLC
CUK
| $3.42M | ﹤0.01% |
+475,276
| New | +$3.66M |
|
2319
CALL
Interactive Brokers
IBKR
$39B
| $3.41M | ﹤0.01% |
188,400
| – | – |
|
2320
PUT
STMicroelectronics
STM
$48.3B
| $3.41M | ﹤0.01% |
+95,800
| New | +$3.38M |
|
|
STR
2321
DELISTED
Sitio Royalties
STR
| $3.41M | ﹤0.01% |
118,080
+102,108
| +639% | +$2.96M |
|
|
PRA
2322
DELISTED
ProAssurance
PRA
| $3.41M | ﹤0.01% |
194,911
+94,256
| +94% | +$1.86M |
|
2323
Blackrock
BLK
$176B
| $3.4M | ﹤0.01% |
4,805
-13,794
| -74% | -$9.21M |
|
|
TGVC
2324
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
| $3.4M | ﹤0.01% |
335,495
| – | – |
|
2325
Allstate
ALL
$66.8B
| $3.4M | ﹤0.01% |
25,065
+14,752
| +143% | +$1.93M |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 476 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 476 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.